EGFR and neoplasm: Previous studies demonstrate the use of RGD polypeptide, cetuximab, and EGFR (epidermal growth factor receptor) aptamer, all of which have targeted effects on tumor tissues (Wang et al., 2016; Narmani et al., 2019; Zhang et al., 2019).